Lexaria Bioscience Corp (LEXX)

[MasterBidder]

Latest investor presentation on their website still claiming:

Advanced discussions underway with 10+ other beverage
and edibles manufacturers with annual sales from $5M to
$50M+ each,
Lexaria targets 5-10% royalty on gross sales plus
individual market territory access fees per licensee,
Future targets will be multi-national manufacturers in
the multi-billion dollar vitamin, supplement, pain
reliever and nicotine marketplaces.


Strange how they claim that but all of existing signed agreements are with companies with 0 to tiny revenues.

Let's see it boys, if ya wanna blow smoke go puff a dart. If you wanna get deals done, then let's get the ball rolling here!